122 related articles for article (PubMed ID: 38719255)
21. Colonoscopic evaluation of diarrhea/colitis occurring as an immune-related adverse event.
Yamauchi Y; Arai M; Akizue N; Ohta Y; Okimoto K; Matsumura T; Fan MM; Imai C; Tawada A; Kato J; Kato N; Takiguchi Y
Jpn J Clin Oncol; 2021 Mar; 51(3):363-370. PubMed ID: 33290513
[TBL] [Abstract][Full Text] [Related]
22. Atezolizumab-associated encephalitis in metastatic lung adenocarcinoma: a case report.
Yamaguchi Y; Nagasawa H; Katagiri Y; Wada M
J Med Case Rep; 2020 Jul; 14(1):88. PubMed ID: 32620173
[TBL] [Abstract][Full Text] [Related]
23. Durable response after immune checkpoint inhibitor-related diabetes in mismatch repair-deficient pancreatic cancer.
Tsang ES; Walker EJ; Carnevale J; Fisher GA; Ko AH
Immunotherapy; 2021 Oct; 13(15):1249-1254. PubMed ID: 34338034
[TBL] [Abstract][Full Text] [Related]
24. Atezolizumab-induced Sclerosing Cholangitis in a patient with lung cancer: A case report.
Nabeshima S; Yamasaki M; Matsumoto N; Takaki S; Nishi Y; Kawamoto K; Taniwaki M; Ohashi N; Hattori N
Cancer Treat Res Commun; 2021; 26():100270. PubMed ID: 33338849
[TBL] [Abstract][Full Text] [Related]
25. The risk of diarrhea and colitis in patients with lung cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis.
Bishay K; Tandon P; Bourassa-Blanchette S; Laurie SA; McCurdy JD
Curr Oncol; 2020 Oct; 27(5):e486-e494. PubMed ID: 33173388
[TBL] [Abstract][Full Text] [Related]
26. Delayed immune-related neutropenia with hepatitis by pembrolizumab.
Nakako S; Nakashima Y; Okamura H; Tani Y; Ueda T; Makuuchi Y; Kuno M; Takakuwa T; Nishimoto M; Koh H; Nakamae H; Hino M
Immunotherapy; 2022 Feb; 14(2):101-105. PubMed ID: 34758635
[TBL] [Abstract][Full Text] [Related]
27. A case of immune checkpoint inhibitor-related colitis with a distinctive endoscopic finding of colonic pseudolipomatosis.
Naito T; Nosaka T; Takahashi K; Ofuji K; Matsuda H; Ohtani M; Hiramatsu K; Imamura Y; Ishizuka T; Nakamoto Y
Clin J Gastroenterol; 2021 Oct; 14(5):1431-1436. PubMed ID: 34106395
[TBL] [Abstract][Full Text] [Related]
28. Acquired idiopathic generalized anhidrosis following pembrolizumab treatment.
Furuta K; Horiguchi A; Nakagawa Y; Kambe N; Kogame T
Clin Exp Dermatol; 2022 Feb; 47(2):463-465. PubMed ID: 34610167
[No Abstract] [Full Text] [Related]
29. Immune Checkpoint Inhibitors-Induced Colitis.
Tian Y; Abu-Sbeih H; Wang Y
Adv Exp Med Biol; 2018; 995():151-157. PubMed ID: 30539510
[TBL] [Abstract][Full Text] [Related]
30. Pancreatic exocrine insufficiency in HIV-positive patients.
Price DA; Schmid ML; Ong EL; Adjukeiwicz KM; Peaston B; Snow MH
HIV Med; 2005 Jan; 6(1):33-6. PubMed ID: 15670250
[TBL] [Abstract][Full Text] [Related]
31. Immune-related organizing pneumonitis in non-small cell lung cancer receiving PD-1 inhibitor treatment: A case report and literature review.
Yin B; Xiao J; Li J; Liu X; Wang J
J Cancer Res Ther; 2020; 16(7):1555-1559. PubMed ID: 33565499
[TBL] [Abstract][Full Text] [Related]
32. Five-year review of corticosteroid duration and complications in the management of immune checkpoint inhibitor-related diarrhoea and colitis in advanced melanoma.
Favara DM; Spain L; Au L; Clark J; Daniels E; Diem S; Chauhan D; Turajlic S; Powell N; Larkin JM; Yousaf N
ESMO Open; 2020 Jul; 5(4):. PubMed ID: 32641348
[TBL] [Abstract][Full Text] [Related]
33. [Successful treatment of Guillain-Barré syndrome-like acute inflammatory demyelinating polyneuropathy caused by pembrolizumab with a combination of corticosteroid and immunoglobulins: a case report].
Hashimoto R; Ueda T; Tsuji Y; Otsuka Y; Sekiguchi K; Matsumoto R
Rinsho Shinkeigaku; 2020 Nov; 60(11):773-777. PubMed ID: 33115993
[TBL] [Abstract][Full Text] [Related]
34. Opportunistic bowel infection after corticosteroid dosage tapering in a stage IV lung cancer patient with tislelizumab-related colitis.
Ni J; Zhang X; Zhang L
Thorac Cancer; 2020 Jun; 11(6):1699-1702. PubMed ID: 32239681
[TBL] [Abstract][Full Text] [Related]
35. Immune checkpoint inhibitor-induced diarrhea: Clinicopathological study of 11 patients.
Yanai S; Nakamura S; Kawasaki K; Toya Y; Akasaka R; Oizumi T; Ishida K; Sugai T; Matsumoto T
Dig Endosc; 2020 May; 32(4):616-620. PubMed ID: 31595568
[TBL] [Abstract][Full Text] [Related]
36. Lipase elevation and type 1 diabetes mellitus related to immune checkpoint inhibitor therapy - A multicentre study of 90 patients from the German Dermatooncology Group.
Grimmelmann I; Momma M; Zimmer L; Hassel JC; Heinzerling L; Pföhler C; Loquai C; Ruini C; Utikal J; Thoms KM; Kähler KC; Eigentler T; Herbst RA; Meier F; Debus D; Berking C; Kochanek C; Ugurel S; Gutzmer R;
Eur J Cancer; 2021 May; 149():1-10. PubMed ID: 33812141
[TBL] [Abstract][Full Text] [Related]
37. IgA nephropathy after pembrolizumab therapy for mesothelioma.
Wang R; Das T; Takou A
BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33257374
[TBL] [Abstract][Full Text] [Related]
38. A real-world data of Immune checkpoint inhibitors in solid tumors from India.
Noronha V; Abraham G; Patil V; Joshi A; Menon N; Mahajan A; Janu A; Jain S; Talreja VT; Kapoor A; Kumar Singh G; Khaddar S; Gupta K; Rathinasamy N; Srinivas S; Agrawal A; Ventrapati P; Prabhash K
Cancer Med; 2021 Mar; 10(5):1525-1534. PubMed ID: 33591635
[TBL] [Abstract][Full Text] [Related]
39. Is exocrine pancreatic insufficiency in adult coeliac disease a cause of persisting symptoms?
Leeds JS; Hopper AD; Hurlstone DP; Edwards SJ; McAlindon ME; Lobo AJ; Donnelly MT; Morley S; Sanders DS
Aliment Pharmacol Ther; 2007 Feb; 25(3):265-71. PubMed ID: 17269988
[TBL] [Abstract][Full Text] [Related]
40. [Pituitary immune-related adverse events induced by programmed cell death protein 1 inhibitors in advanced lung cancer patients: A report of 3 cases].
Gu YC; Liu Y; Xie C; Cao BS
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 54(2):369-375. PubMed ID: 35435206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
